Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
7 Leser
Artikel bewerten:
(0)

Kinston Pulmonary Associates Partners with TSI Healthcare for Pulmonary & Sleep Medicine EHR

CHAPEL HILL, N.C., March 4, 2014 /PRNewswire/ -- TSI Healthcare, a national leader in the sales and support of customized NextGen® Practice Management and Electronic Health Record solutions for Pulmonary & Sleep Medicine, announced today its partnership with Kinston Pulmonary Associates. Dr. Robert Gallaher of Kinston Pulmonary Associates has been practicing medicine for more than 20 years and is nationally recognized for his diagnosis and treatment of COPD, asthma, emphysema, and sleep apnea.

Implementing a fully integrated system focused on Pulmonary & Sleep Medicine specific content was important to Dr. Gallaher as he investigated numerous companies and systems around the country. Their selection was based on the strength and integration of the NextGen product suite coupled with TSI Healthcare's unique Pulmonary & Sleep Medicine content and their national reputation for excellence in training, service and support.

"We have never regretted our decision to partner with TSI Healthcare and we recommend them toall of our peers. Who knew EHR implementation could be so easy?" says Dr. Gallaher.

Dr. Gallaher and the staff at Kinston Pulmonary have used their integrated Pulmonary & Sleep Medicine EHR system to save valuable time in documenting patient care. TSI Healthcare's Pulmonary ScoreCard', featuring a one-page graphical view of a patient's pulse oximetry, spirometry, vitals, Epworth Sleepiness Scale, and QIDS scores, provides the caregivers all of the requisite trending information in one convenient place.

"We are very excited to have Kinston Pulmonary Associates join our family of valued clients and appreciate their confidence in us," said Richard Pedersen, Senior Vice President and Chief Marketing Officer at TSI Healthcare. "We are committed to helping them continue to streamline their practice as they deliver a higher quality of care and improve outcomes for all of their patients."

About TSI Healthcare
TSI Healthcare, founded in 1997, is a national leader in the sales and support of customized NextGen® Practice Management and Electronic Health Record solutions for Pulmonary & Sleep Medicine. TSI Healthcare's solutions are designed to meet the unique needs of specialty practices through Pulmonary & Sleep Medicine EHR content, unmatched services, and award winning software. In addition to core products powered by NextGen, TSI Healthcare also offers Patient Portal, Revenue Cycle Management, cloud hosting and more. TSI Healthcare's support and service teams include NextGen Certified Professionals, clinicians, and former practice administrators. The entire team is dedicated to the complete and measurable success of each client supported by TSI Healthcare. For more information, visit www.tsihealthcare.com or call 800-354-4205.

CONTACT: Trish O'Malley, Director of Marketing, 1-800-354-4205, POMalley@tsihealthcare.com

SOURCE TSI Healthcare

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.